Literature DB >> 8230028

Adult respiratory distress syndrome associated with antiphospholipid antibody syndrome.

S Ghosh1, H D Walters, J H Joist, T G Osborn, T L Moore.   

Abstract

Antiphospholipid antibody syndrome (APS) has been shown to be associated with arterial and venous thromboses, recurrent miscarriages, and thrombocytopenia. We describe 3 cases of adult respiratory distress syndrome (ARDS) in patients with primary APS. The autopsy in one patient revealed no evidence of vasculitis, but extensive small vessel thrombosis of multiple organs including the lungs was seen. No infectious process, connective tissue diseases, or pulmonary edema could be documented and there was no clinical or laboratory evidence of vasculitis in the other 2 patients. The 2 patients who survived responded dramatically to intravenous steroids.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8230028

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

Review 1.  The lung in the antiphospholipid syndrome.

Authors:  G Espinosa; R Cervera; J Font; R A Asherson
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

Review 2.  Unusual manifestations of the antiphospholipid syndrome.

Authors:  Ronald A Asherson; Ricard Cervera
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

Review 3.  [Antiphospholipid antibody syndrome].

Authors:  R Schmidt; E H Scheuermann; A Viertel; H Geiger; I Scharrer
Journal:  Med Klin (Munich)       Date:  1999-02-15

4.  A case of catastrophic antiphospholipid syndrome presenting with acute respiratory distress syndrome as the initial manifestation.

Authors:  Kazushi Kinjo; Hiroya Terabe; Megumi Ogawa; Hideki Takeda; Doki Cho; Shinichi Hoshino; Takeshi Miyahira; Mariko Oshiro
Journal:  Rheumatol Int       Date:  2008-07-24       Impact factor: 3.580

Review 5.  Clinical Insights into Diffuse Alveolar Hemorrhage in Antiphospholipid Syndrome.

Authors:  Sarah Abramson Stoots; Lindsay Lief; Doruk Erkan
Journal:  Curr Rheumatol Rep       Date:  2019-09-06       Impact factor: 4.592

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.